Overview

Pharmacokinetic Response to BPI in Burns

Status:
Terminated

Trial end date:
2007-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety of a protein called BPI that is naturally made by the body's white blood cells to fight infection.

Phase:

Phase 2

Details

Lead Sponsor:

University of Texas Southwestern Medical Center

Treatments:

Bactericidal permeability increasing protein